Page 266 - Drug Class Review
P. 266
Page 163 of 205
Drug Effectiveness Review Project
Primary Outcome Measures: Adverse events noted during 6 months after first prescription for DON Timing of assessments: 6 months after first prescription for the drug
Groups similar at baseline: N/A
Alzheimer classification: NR
Health Outcome Measures: NR
donepezil 72.9 58 NR NR Secondary Outcome Measures: NR See adverse events (incidence > 5% reported) Intermediate Outcome Measures:
• •
Final Report Update 1 Authors: Dunn et al. Year: 2000 POPULATION CHARACTERISTICS: Mean age (years): Sex (% female): Ethnicity: Other germane population qualities: OUTCOME ASSESSMENT: RESULTS: Alzheimer's Drugs